Clinical Trials Browser

Phase 1 × prexasertib × Tumor-Agnostic × Clear all

NCT03495323 2021-04-15

A Study of Prexasertib (LY2606368), CHK1 Inhibitor, and LY3300054, PD-L1 Inhibitor, in Patients With Advanced Solid Tumors

Phase 1 Completed

Neoplasms

NCT02514603 2017-05-22

A Study of Prexasertib (LY2606368) in Japanese Participants With Advanced Cancers

Phase 1 Completed

Neoplasm Metastasis, Neoplasms